- Filed
- May 13, 2026 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2026 · Apr 25, 2026 | 230.21M sh |
| Shares Diluted | Q1 2026 · Mar 31, 2026 | 230.21M sh |
| Shares Diluted | Q1 2026 · Mar 31, 2025 | 200M sh |
| Operating Cash Flow | Q1 2026 · Mar 31, 2026 | −$2.67M |
| Operating Cash Flow restated | Q1 2026 · Mar 31, 2025 | −$399K |
| Cash And Equivalents | Q1 2026 · Mar 31, 2026 | $103K |
| Cash And Equivalents | Q1 2026 · Dec 31, 2025 | $20K |
| Stockholders Equity | Q1 2026 · Mar 31, 2026 | −$25.33M |
| Stockholders Equity | Q1 2026 · Dec 31, 2025 | −$20.75M |
| Stockholders Equity restated | Q1 2026 · Mar 31, 2025 | −$43.45M |
| Stockholders Equity restated | Q1 2026 · Dec 31, 2024 | −$42.78M |
| Current Liabilities | Q1 2026 · Mar 31, 2026 | $10.38M |
| Current Liabilities | Q1 2026 · Dec 31, 2025 | $10.17M |
| Total Liabilities | Q1 2026 · Mar 31, 2026 | $27.3M |
| Total Liabilities | Q1 2026 · Dec 31, 2025 | $22.1M |
| Current Assets | Q1 2026 · Mar 31, 2026 | $1.22M |
| Current Assets | Q1 2026 · Dec 31, 2025 | $596K |
| Total Assets | Q1 2026 · Mar 31, 2026 | $1.97M |
| Total Assets | Q1 2026 · Dec 31, 2025 | $1.35M |
| Eps Diluted | Q1 2026 · Mar 31, 2026 | −$0.02 |
| Eps Diluted | Q1 2026 · Mar 31, 2025 | −$0.01 |
| Eps Basic | Q1 2026 · Mar 31, 2026 | −$0.02 |
| Eps Basic | Q1 2026 · Mar 31, 2025 | −$0.01 |
| Sga Expense | Q1 2026 · Mar 31, 2026 | $3.31M |
| Sga Expense | Q1 2026 · Mar 31, 2025 | $478K |
| Rd Expense | Q1 2026 · Mar 31, 2026 | $1.27M |
| Rd Expense | Q1 2026 · Mar 31, 2025 | $187K |
| Net Income | Q1 2026 · Mar 31, 2026 | −$4.58M |
| Net Income restated | Q1 2026 · Mar 31, 2025 | −$665K |
| Operating Income | Q1 2026 · Mar 31, 2026 | −$4.58M |
| Operating Income restated | Q1 2026 · Mar 31, 2025 | −$665K |